BlackRock Inc. Invests $155.50 Million in U.S. Physical Therapy, Inc. $USPH

BlackRock Inc. bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,264,202 shares of the company's stock, valued at approximately $155,505,000. BlackRock Inc. owned about 14.88% of U.S. Physical Therapy at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Deutsche Bank AG purchased a new position in U.S. Physical Therapy in the second quarter valued at approximately $1,119,000. Rice Hall James & Associates LLC acquired a new stake in U.S. Physical Therapy in the 2nd quarter valued at $1,279,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in U.S. Physical Therapy in the 2nd quarter valued at $30,000. Simplicity Wealth LLC purchased a new position in U.S. Physical Therapy in the second quarter valued at about $576,000. Finally, Bank of New York Mellon Corp purchased a new position in U.S. Physical Therapy in the second quarter valued at about $9,087,000.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $78.61 on Friday. U.S. Physical Therapy, Inc. has a fifty-two week low of $58.19 and a fifty-two week high of $93.50. The business has a 50 day moving average price of $74.97 and a two-hundred day moving average price of $73.71. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. The firm has a market cap of $1.17 billion, a PE ratio of 462.44, a price-to-earnings-growth ratio of 2.18 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.75 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The business's revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.81 earnings per share. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.95 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy's dividend payout ratio is 1,082.35%.

Insiders Place Their Bets

In related news, Director Peter Francis Minan acquired 492 shares of the firm's stock in a transaction on Monday, June 8th. The stock was bought at an average cost of $63.14 per share, with a total value of $31,064.88. Following the acquisition, the director directly owned 2,923 shares in the company, valued at approximately $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

USPH has been the subject of a number of recent research reports. Citizens Jmp reiterated a "market outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a report on Wednesday. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a research report on Monday, August 10th. Citigroup reaffirmed a "market outperform" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Finally, Zacks Research upgraded shares of U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a research note on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and a consensus target price of $99.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source